BioSante Pharmaceuticals, Inc. BPAX today announced that ISS PROXY
ADVISORY SERVICES, an independent proxy advisory firm, has recommended that
BioSante stockholders vote “FOR” the adoption of the merger agreement between
BioSante and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. at
BioSante's upcoming special meeting of stockholders scheduled to be held on
March 15, 2013.
In recommending that the merger transaction be approved, ISS noted, “(T)hus,
in light of the reasonable strategic rationale for the merger and the
potential value received by BioSante shareholders, support for this merger is
warranted.”*
BioSante encourages all stockholders to vote their shares promptly by phone,
Internet or by mailing their proxy card. The board of directors of BioSante
unanimously recommends that stockholders vote “FOR” the adoption of the merger
agreement and all related matters being submitted to a vote of BioSante
stockholders.
BioSante stockholders who need assistance in voting their shares or who have
questions regarding BioSante's special meeting may contact The BioSante Proxy
Information Line toll-free at (800) 357-9167 or AST Phoenix Advisors at (877)
478-5038.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in